isopentenyl pyrophosphate has been researched along with Disease Exacerbation in 1 studies
isopentenyl pyrophosphate: substrate for isopentenyl pyrophosphate isomerase; RN given refers to unlabeled cpd; a nonpeptide mycobacterial antigen that stimulates gamma delta T cells
isopentenyl diphosphate : A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine this approach in breast cancer, a Phase I trial was conducted in which zoledronate, a Vgamma9Vdelta2 T cell agonist, plus low-dose interleukin (IL)-2 were administered to 10 therapeutically terminal, advanced metastatic breast cancer patients." | 2.75 | In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. ( Buccheri, S; Caccamo, N; Cicero, G; D'Asaro, M; Dieli, F; Eberl, M; Guggino, G; Hayday, AC; La Mendola, C; Meraviglia, S; Orlando, V; Roberts, A; Scarpa, F; Stassi, G; Todaro, M; Vermijlen, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meraviglia, S | 1 |
| Eberl, M | 1 |
| Vermijlen, D | 1 |
| Todaro, M | 1 |
| Buccheri, S | 1 |
| Cicero, G | 1 |
| La Mendola, C | 1 |
| Guggino, G | 1 |
| D'Asaro, M | 1 |
| Orlando, V | 1 |
| Scarpa, F | 1 |
| Roberts, A | 1 |
| Caccamo, N | 1 |
| Stassi, G | 1 |
| Dieli, F | 1 |
| Hayday, AC | 1 |
1 trial available for isopentenyl pyrophosphate and Disease Exacerbation
| Article | Year |
|---|---|
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
Topics: Adjuvants, Immunologic; Aged; Breast Neoplasms; Cell Proliferation; Chemokines; Cytokines; Diphospho | 2010 |